BDBM301958 3-(4-(4-(4,6-Dimethylpyrimidin-2-yl)piperazin-1-yl)butyl)-5-methoxy-1H-indole::US9598401, Example 12
SMILES: COc1ccc2[nH]cc(CCCCN3CCN(CC3)c3nc(C)cc(C)n3)c2c1
InChI Key: InChIKey=MAADDEJQBZZFGO-UHFFFAOYSA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM301958 (3-(4-(4-(4,6-Dimethylpyrimidin-2-yl)piperazin-1-yl...) | PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SUNSHINE LAKE PHARMA CO., LTD. US Patent | Assay Description Human HEK-293 cell homogenates (36 μg protein) were incubated at 22° C. for 60 minutes with 0.3 nM [3H]8-OH-DPAT (Perkin-Elmer) in the absence o... | US Patent US9598401 (2017) BindingDB Entry DOI: 10.7270/Q2GH9M1F | |||||||||||
More data for this Ligand-Target Pair |